Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

CLENZ-LYTE

POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE

Standard Dose
236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/BOT;22.74GM/BOT
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview CLENZ-LYTE is listed in Drugs@FDA under application 090769 (ANDA).

Marketing status: Discontinued Active ingredient POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE Form and strength FOR SOLUTION;ORAL - 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/BOT;22.74GM/BOT Sponsor PADDOCK LLC Submission history Latest submission status date: 2010-06-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview CLENZ-LYTE is listed in Drugs@FDA under application 090769 (ANDA). Marketing status: Discontinued Active ingredient POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE Form and strength FOR SOLUTION;ORAL - 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/BOT;22.74GM/BOT Sponsor PADDOCK LLC Submission history Latest submission status date: 2010-06-07 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.